These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 20671626)
21. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials. Kuan YC; Wu D; Huang KW; Chi NF; Hu CJ; Chung CC; Tam KW; Huang YH Clin Ther; 2016 Apr; 38(4):874-88. PubMed ID: 26923035 [TBL] [Abstract][Full Text] [Related]
22. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis. Alshaikh MK; Tricco AC; Tashkandi M; Mamdani M; Straus SE; BaHammam AS J Clin Sleep Med; 2012 Aug; 8(4):451-8. PubMed ID: 22893778 [TBL] [Abstract][Full Text] [Related]
23. Modafinil in diurnal sleepiness. A study of 123 patients. Laffont F; Mayer G; Minz M Sleep; 1994 Dec; 17(8 Suppl):S113-5. PubMed ID: 7701192 [TBL] [Abstract][Full Text] [Related]
24. Modafinil: a second look. Confirmed efficacy in narcolepsy. Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564 [TBL] [Abstract][Full Text] [Related]
25. Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials. Meskill GJ; Davis CW; Zarycranski D; Doliba M; Schwartz JC; Dayno JM CNS Drugs; 2022 Jan; 36(1):61-69. PubMed ID: 34935103 [TBL] [Abstract][Full Text] [Related]
26. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate. Huang YS; Guilleminault C Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267 [TBL] [Abstract][Full Text] [Related]
27. Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies. Thorpy MJ; Schwartz JR; Kovacevic-Ristanovic R; Hayduk R Psychopharmacology (Berl); 2003 Jun; 167(4):380-5. PubMed ID: 12709775 [TBL] [Abstract][Full Text] [Related]
28. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628 [TBL] [Abstract][Full Text] [Related]
29. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437 [TBL] [Abstract][Full Text] [Related]
30. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. Lavault S; Dauvilliers Y; Drouot X; Leu-Semenescu S; Golmard JL; Lecendreux M; Franco P; Arnulf I Sleep Med; 2011 Jun; 12(6):550-6. PubMed ID: 21576035 [TBL] [Abstract][Full Text] [Related]
31. Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial. Dauvilliers Y; Shapiro C; Mayer G; Lammers GJ; Emsellem H; Plazzi G; Chen D; Carter LP; Lee L; Black J; Thorpy MJ CNS Drugs; 2020 Jul; 34(7):773-784. PubMed ID: 32588401 [TBL] [Abstract][Full Text] [Related]
32. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial. Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166 [TBL] [Abstract][Full Text] [Related]
33. Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy. McClellan KJ; Spencer CM CNS Drugs; 1998 Apr; 9(4):311-24. PubMed ID: 27521015 [TBL] [Abstract][Full Text] [Related]
34. Multiple treatment comparison in narcolepsy: a network meta-analysis. Lehert P; Falissard B Sleep; 2018 Dec; 41(12):. PubMed ID: 30239930 [TBL] [Abstract][Full Text] [Related]
35. Use of modafinil in the treatment of narcolepsy: a long term follow-up study. Besset A; Chetrit M; Carlander B; Billiard M Neurophysiol Clin; 1996; 26(1):60-6. PubMed ID: 8657099 [TBL] [Abstract][Full Text] [Related]
36. [The effects of modafinil (300mg) on sleep, sleepiness and arousal in narcoleptic patients]. Besset A; Tafti M; Villemin E; Billiard M Neurophysiol Clin; 1993 Jan; 23(1):47-60. PubMed ID: 8095321 [TBL] [Abstract][Full Text] [Related]
37. Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness. Schwartz JR; Feldman NT; Bogan RK J Neuropsychiatry Clin Neurosci; 2005; 17(3):405-12. PubMed ID: 16179665 [TBL] [Abstract][Full Text] [Related]
38. Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial. Philip P; Chaufton C; Taillard J; Capelli A; Coste O; Léger D; Moore N; Sagaspe P Sleep; 2014 Mar; 37(3):483-7. PubMed ID: 24587570 [TBL] [Abstract][Full Text] [Related]
39. Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis. Xu XM; Wei YD; Liu Y; Li ZX Sleep Med; 2019 Dec; 64():62-70. PubMed ID: 31671326 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Jasinski DR; Kovacević-Ristanović R Clin Neuropharmacol; 2000; 23(3):149-56. PubMed ID: 10895398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]